The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...